State Street’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

State Street’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-190,818	Closed	-$5.33M	–	3865
2019 Q3	$5.33M	Sell	190,818 -14,636	-7%	-$237K	﹤0.01%	2755
2019 Q2	$2.9M	Sell	205,454 -9,803	-5%	-$93.2K	﹤0.01%	3083
2019 Q1	$1.91M	Buy	215,257 +10,036	+5%	+$81.5K	﹤0.01%	3167
2018 Q4	$1.56M	Sell	205,221 -1,260	-0.6%	-$20.3K	﹤0.01%	3210
2018 Q3	$4.33M	Buy	206,481 +21,323	+12%	+$508K	﹤0.01%	2918
2018 Q2	$5.54M	Buy	185,158 +98,816	+114%	+$2.69M	﹤0.01%	2809
2018 Q1	$2.34M	Buy	86,342 +32,900	+62%	+$984K	﹤0.01%	3103
2017 Q4	$1.54M	Buy	53,442 +19,180	+56%	+$526K	﹤0.01%	3261
2017 Q3	$833K	Buy	+34,262	New	+$812K	﹤0.01%	3412

State Street's DOVA Position: Q4 2019 in Review

State Street sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 190,818 shares — an estimated $5.33M sold.

State Street first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $5.54M in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

State Street reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
State Street sold 190,818 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $5.33M.
State Street first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
State Street's Dova Pharmaceuticals, Inc. Common Stock position peaked at $5.54M in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.